Almost 20 years’ worth of follow-up in an international registry shows that patients with degenerative mitral regurgitation who underwent mitral valve (MV) repair had better survival, fewer ...

Bioprosthetic valves lasts about 10-15 years. These are usually obtained from animals or human organ donors. Tissue valves seem to improve the patient’s hemodynamics, but tend to stiffen in 10-15 ...

Research, along with guidelines from the American Heart Association® (AHA), indicates that patients who have primary mitral regurgitation would benefit from mitral valve repair rather than replacement ...

Bioprosthetic valves lasts about 10-15 years. These are usually obtained from animals or human organ donors. Tissue valves seem to improve the patient’s hemodynamics, but tend to stiffen in 10-15 ...

Patients who underwent mitral valve replacement had a more than threefold higher 10-year rate of infective endocarditis than those at moderate risk for the disease, whereas undergoing mitral valve ...

(RTTNews) - Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne transcatheter mitral valve replacement (TMVR) system to ...

Piedmont Heart Institute (PHI) physicians Pradeep K. Yadav, M.D., Director of Structural Interventions, and Vinod H. Thourani, M.D., Marcus Chairman of Cardiovascular Surgery, successfully performed ...

Edwards Lifesciences is paying up to $690 million to a buy an Israeli company that makes transcatheter mitral valve and tricuspid repair devices. Last year it bought a mitral valve replacement company ...

Please provide your email address to receive an email when new articles are posted on . Among patients who underwent transcatheter mitral valve replacement for severe mitral regurgitation, 93% of ...

CONGENITAL mitral stenosis, sufficiently severe to cause recurrent heart failure and syncopal episodes in infancy, is rarely compatible with life beyond two years of age. 1 Except for 1 reported case ...